Stay updated on LY3471851 in Eczema: Clinical Trial
Sign up to get notified when there's something new on the LY3471851 in Eczema: Clinical Trial page.

Latest updates to the LY3471851 in Eczema: Clinical Trial page
- CheckyesterdayNo Change Detected
- Check8 days agoChange DetectedThe web page has been updated from version 2.15.0 to version 2.15.2.SummaryDifference0.1%
- Check15 days agoNo Change Detected
- Check22 days agoChange DetectedThe page has undergone significant content changes, including the removal of detailed study information regarding the safety and side effects of LY3471851 for atopic dermatitis, while adding new identifiers and collaborators.SummaryDifference11%
- Check30 days agoChange DetectedThe web page has been updated from version 2.14.3 to version 2.14.4.SummaryDifference0.1%
- Check73 days agoChange DetectedThe page has removed a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products, along with contact information for assistance.SummaryDifference2%
- Check88 days agoChange DetectedThe web page now includes a notice about heavy traffic affecting the performance and availability of some NLM-NCBI services and products, along with contact information for assistance.SummaryDifference2%
- Check95 days agoChange DetectedThe website has been updated from version v2.14.1 to v2.14.2.SummaryDifference0.1%
Stay in the know with updates to LY3471851 in Eczema: Clinical Trial
Enter your email address, and we'll notify you when there's something new on the LY3471851 in Eczema: Clinical Trial page.